Journal Guide

The development of new anticancer agents is one of the most rapidly changing aspects of cancer research. Investigational New Drugs provides a forum for the rapid dissemination of information on new anticancer agents. The papers published are of interest to the medical chemist, toxicologist, pharmacist, pharmacologist, biostatistician and clinical oncologist. Investigational New Drugs provides the fastest possible publication of new discoveries and results for the whole community of scientists developing anticancer agents.

Each issue contains original articles dealing with anticancer drug development. Other sections are devoted to invited review articles and letters to the editor. The journal also affords the opportunity to publish the proceedings of special workshops and symposia devoted to the development of new anticancer agents. Provided they add to the understanding of the investigational agents, the journal is not adverse to publishing clinical trials with negative results.

Investigatio

The Journal de Pharmacie Clinique is a reference work for all hospital pharmacists, researchers, and pharmaceutical industry professionals. The journal reports the latest results in applied hospital research, therapeutic innovations, the utilization of medicines and pharmaco-economic assessments. It is also an excellent aid for course-teaching and students preparing for examinations. The online version of Journal de Pharmacie Clinique is available. All articles published since 1997 can now be accessed online. Recent articles are available by pay per view or by subscription while older ones have free access.

Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine, is a peer-reviewed publication focusing on the latest research developments in addiction medicine as well as on treatment innovations and ethical, economic, forensic, and social topics. The journal is indispensable reading for all physicians and mental health professionals who need to keep up-to-date with the state of the art in research, clinical practice, and education in addiction medicine. Journal of Addiction Medicine covers a wide range of relevant topics including addiction in pregnancy, adolescent addiction, the drug-exposed neonate, pharmacology, neuroimaging techniques, treatment of special populations, treatment of addiction-related disorders, gambling addiction, pathophysiology of addiction, biological and non-biological therapies, and issues in graduate medical education. Journal of Addiction Medicine provides a platform to publish and discuss leading and future therapies in this rapidly-changing field. The journal bridges research and practice, providing insights and solutions to enhance patient care and outcomes.

Journal of Aerosol Medicine and Pulmonary Drug Delivery is the only authoritative journal focusing on aerosol use in medicine, new drug delivery systems, cutting-edge research, and new innovative therapies and clinical applications. All aspects of aerosol research in medicine are covered including pulmonary drug delivery, airway reactivity and asthma treatment, inhalation of particles and gases in the respiratory tract, toxic effects of inhaled agents, and aerosols as tools for studying basic physiologic phenomena.

The Journal of Antimicrobial Chemotherapy is among the foremost international journals in antimicrobial research. Our readership includes representatives of academia, industry and health services, and includes those who are influential in formulary decisions.Published monthly, the Journal features original articles on the laboratory aspects and clinical use of antimicrobials including antibacterial, antiviral, antifungal, and antiprotozoal agents.In addition to the wealth of primary papers, the journal carries review articles offering in-depth discussion on matters of topical concern. Lively leading articles offer incisive coverage of recent advances and controversies.Other sections include: * For debate: International comment on contentious issues and ideas * Antimicrobial practice: Articles on practical prescribing and formulary issues * Correspondence: A section for scientists to present early observations of their work and to comment on published articles * Book reviews: Helpful reviews of relevant, newly published titles A carefully organised format directs you to areas of interest.Monthly issues can include up to ten informative sections: * Leading articles * Reviews * The Garrod Lecture * For debate * Original articles * Brief reports * Antimicrobial practice * Meeting reports * Correspondence * Book reviews The Journal publishes between two and eight supplements each year. These include Working Party reports of the British Society for Antimicrobial Chemotherapy, and original publications on pre-clinical and clinical aspects of drugs in development or the role of established drugs in specific therapeutic areas.

Journal of Biomedical Science is an open access, peer-reviewed journal that encompasses all fundamental and molecular aspects of basic medical sciences, emphasizing on providing the molecular studies of biomedical problems and molecular mechanisms.

The Journal of Biopharmaceutical Statistics, a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to such work in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers: * drug, device, and biological research and development * drug screening and drug design * assessment of pharmacological activity * pharmaceutical formulation and scale-up * preclinical safety assessment * bioavailability, bioequivalence, and pharmacokinetics * phase, I, II, and III clinical development * premarket approval assessment of clinical safety * postmarketing surveillance Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.

DON'T MISS A BEAT!Every informative issue of the Journal of Cardiovascular Pharmacology and Therapeutics (JCPT) offers cardiologists, clinical pharmacologists and researchers involved in disease relevant clinical and experimental investigations of newer cardiovascular drugs and other therapeutic options. Four times a year, JCPT examines and analyzes arenas such as: o Agents that Reduce Myocardial Infarct Size o Agents that Reduce Myocardial Remodeling o Angiotensin Converting Enzyme Inhibitors o Antihypertensive Therapy o Arrhythmias o Atrial Fibrillation o Beta-Blocker Therapies o Cardioembolic Stroke o Cardiomyopathy o Cardioprotective Agents o Cardiopulmonary Resuscitation o Cardiovascular Combination Therapies o Chronic Angina o Chronic Cardiac Ischemia o Congestive Heart Failure o Coronary Artery Disease o Coronary Revascularization o Heparin Therapies o Hypertension o Hypotension o Implantable Devices o Ischemic Heart Disease o Myocardial Infarction o Percutaneous Coronary Interventions o Peripheral Arterial Disease o Preconditioning/Postconditioning o Regenerative Cardiology o Stem Cell TherapyAmong the drug classes regularly evaluated are: ACE inhibitors * angiotensin receptor blockers * anti-anginals * anti-arrhythmics * anti-coagulants * anti-hypertensives * anti-thrombins * beta-blockers * calcium channel blockers * cardioprotective agents * cardiotonic agents * direct renin inhibitors * diuretics * fibrinolytic agents * heart rate modulats * plasminogen activators * QT prolonging drugs * statins * vasoconstrictor agents * and vasodilator agents.The journal features original articles, topical journal supplements, reviews, clinical and experimental investigations, and commentaries written by respected practitioners from all over the world.

SUBSCRIBE TO THE Journal of Chemotherapyto help keep you up-to-date on antimicrobial chemotherapy,anticancer chemotherapy, immunomodulating chemotherapy,experimental and clinical studies in these fields published bimonthly.

Journal of Child and Adolescent Psychopharmacology is a peer-reviewed journal covering the clinical aspects of treating adolescents and children with psychotropic medications. The Journal encompasses treatment techniques, clinical management, investigative research, and health policy.Coverage includes:• The most up-to-date information on new drugs and treatment strategies• Analysis of biological aspects of psychopathology• In-depth studies on the adverse drug effects following treatment of psychiatric disorders• Information on related areas of medical sciences• Related news and issues in child and adolescent psychopharmacology.

This leading publication in psychopharmacology offers a wide range of articles that report on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, medico-legal issues, and psychiatric effects of non-psychiatric drugs. The Journal keeps psychiatrists and psychiatric residents up-to-date on the latest clinical developments in the psychotropics, presenting the extensive coverage needed to keep up with every development in this fast-growing field. For more information, visit www.psychopharmacology.com.

THE JOURNAL OF DIETARY SUPPLEMENTS (formerly the Journal of Herbal Pharmacotherapy), is a leading voice in the dietary supplement industry. Published quarterly, the journal provides a much-needed forum to guide the industry’s development as a science-based entity. Under the leadership of Editor-in-Chief Catherine Ulbricht, founder of the Natural Standard Research Collaboration, JDS will keep you informed on the most up-to-date issues of the dietary supplement industry using rigorous scientific research and practical applications of that research. Read More: http://informahealthcare.com/loi/jds.

The Journal of Infection and Chemotherapy (JIC) publishes original papers, laboratory or clinical, as well as case reports and notes from all parts of the world on all aspects of chemotherapy, covering the pathogenesis, diagnosis, treatment, and control of infection, including treatment with anticancer drugs. Offerings include experimental studies on animal models and pharmacokinetics, and reports on epidemiology and clinical trials. The Journal of Infection and Chemotherapy is the official journal of the Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases.